We are excited to be speaking at the Bioprocessing Summit Europe 2026, in Barcelona, Spain this March, 2026.
Bioprocessing Summit Europe brings together 650+ professionals from industry and academia, along with 60+ exhibitors, to advance the manufacture, quality, and control of cutting-edge biologics, genetic therapies, peptides, and oligonucleotides.
Hear live from Cell and Gene Therapy Catapult
Title: Digitalised Platforms for Driving Quality and Accelerating Cell-Therapy Development
Speaker: Jahid Hasan, PhD, Lead, Technical, Cell and Gene Therapy Catapult
Overview: Cell therapies are at a critical juncture with patient demand outstripping current manufacturing capacity. To address this challenge, the Cell and Gene Therapy Catapult has developed cell therapy manufacturing platforms that offer step-changes in throughput for autologous and allogeneic products by integrating end-to-end automation and digitising data flow and decision-making.
Date and time: March 10, 2026 at 02:20 PM
Track: Process Modelling and Digitalisation
Title: Next-Gen rAAV Manufacturing: Continuous, Intensified, and Smart by Design
Speaker: Maria Barreira Gonzalez, PhD, Programme Head of Gene Modification, Cell & Gene Therapy Catapult
Overview: The Cell and Gene Therapy Catapult (CGTC) is advancing cost-effective, next-generation rAAV manufacturing by developing continuous and intensified upstream processes that enhance productivity, scalability, and consistency. Complementing this, process and mechanistic modelling, integrated with Process Analytical Technology (PAT) and automation, provides real-time monitoring, predictive insights, and adaptive control. Together, these innovations create smart-by-design platforms that accelerate development, reduce costs, and enable robust rAAV manufacturing at commercial scale.
Date and time: March 11, 2026 at 05:30 PM
Track: Intensified and Continuous Processing
Title: Advancing rAAV Manufacturing: Continuous DSP Integrated with Digital Process Development
Speaker: Bilal Ozdoganoglu, Associate Senior Scientist, Cell and Gene Therapy Catapult
Overview: As demand for rAAV gene therapies grows, continuous downstream processing (DSP) is key to achieving scalable, cost-effective, and safe manufacturing. This work integrates mechanistic modelling, digital twins, and Process Analytical Technology (PAT) to enable real-time monitoring, simulation, and optimisation. The approach improves process efficiency and consistency, supporting faster production and robust quality control—essential for meeting clinical and commercial needs in a rapidly evolving gene therapy landscape.
Date and time: March 12, 2026 at 01:30 PM
Track: Advances in Recovery and Purification - Part 2